Kelly Lau

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A

Brian Long, P. Véron, Klaudia Kuranda et al. · Molecular Therapy · 2020 · 73 citations · Full text

Medicine, Hematology, Immunology +11

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials

Soumi Gupta, Kelly Lau, Cary O. Harding et al. · EBioMedicine · 2018 · 72 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial

Becky Schweighardt, Troy Tompkins, Kelly Lau et al. · Clinical Therapeutics · 2014 · 57 citations

Medicine, Immunology, Pharmacology +5

Diagnostic clues to megaloblastic anaemia without macrocytosis

Clement Wn Chan, S. Y. H. LIU, Chi Shan Kho et al. · International Journal of Laboratory Hematology · 2007 · 38 citations

Medicine, Hematology, Pathology +16

Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up

Barbara K. Burton, Nicola Longo, Jerry Vockley et al. · Molecular Genetics and Metabolism · 2020 · 32 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13